Risk for ingestion of toxic substances in children with Prader-Willi syndrome

Shawn E McCandless1, Karen Potter Powell, Ulrika Sandberg

  • 1Case Western Reserve University and University Hospitals Case Medical Center, Cleveland, Ohio, USA. shawn.mccandless@case.edu

Insights

Individuals with Prader-Willi syndrome (PWS) face a significantly higher risk of ingesting toxins. This increased risk, linked to PWS behaviors, necessitates greater awareness among healthcare providers and poison control centers.

Area of Science:

  • Genetics
  • Pediatrics
  • Toxicology

Background:

  • Prader-Willi syndrome (PWS) is associated with behaviors that may increase the risk of ingesting dangerous items.
  • Limited data exists on the prevalence of toxic ingestions in individuals with PWS compared to controls.

Purpose of the Study:

  • To determine if individuals with PWS have a higher prevalence of toxic ingestions.
  • To identify PWS-related factors associated with toxic ingestion.
  • To inform genetic counseling and clinical management strategies.

Main Methods:

  • An online survey was administered to parents/caretakers of individuals with PWS and their non-PWS siblings.
  • Data collected included a history of toxic ingestions.
  • PWS subjects (N=130) and sibling controls (N=134) aged 2-18 years were analyzed.

Main Results:

  • Toxic ingestion was significantly more prevalent in PWS subjects (20%) compared to controls (2%).
  • PWS-related features such as food searching, pica, and decreased cognitive ability were associated with increased toxic ingestion.
  • PWS children demonstrated an approximately 12-fold increased risk of toxin ingestion.

Conclusions:

  • Individuals with PWS exhibit a substantially elevated risk of toxic ingestions.
  • Geneticists and primary care providers should be informed to guide counseling and preventative measures.
  • Poison control centers require awareness of PWS-associated factors for effective diagnosis and management of ingestions.

Related Concept Videos

Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...